ImmunoPET for prostate cancer in the PSMA era : do we need other targets?
dc.contributor.author | Filippi, Luca | |
dc.contributor.author | Evangelista, Laura | |
dc.contributor.author | Sathekge, Mike Machaba | |
dc.contributor.author | Schillaci, Orazio | |
dc.date.accessioned | 2023-06-09T07:02:04Z | |
dc.date.issued | 2022-12 | |
dc.description.abstract | Please read abstract in the article. | en_US |
dc.description.department | Nuclear Medicine | en_US |
dc.description.embargo | 2023-08-21 | |
dc.description.librarian | hj2023 | en_US |
dc.description.uri | https://link.springer.com/journal/40336 | en_US |
dc.identifier.citation | Filippi, L., Evangelista, L., Sathekge, M.M. et al. ImmunoPET for prostate cancer in the PSMA era: do we need other targets? Clinical and Translational Imaging 10, 587–596 (2022). https://doi.org/10.1007/s40336-022-00520-w. | en_US |
dc.identifier.issn | 2281-5872 (print) | |
dc.identifier.issn | 2281-7565 (online) | |
dc.identifier.other | 10.1007/s40336-022-00520-w | |
dc.identifier.uri | http://hdl.handle.net/2263/91067 | |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.rights | © The Author(s), under exclusive licence to Italian Association of Nuclear Medicine and Molecular Imaging 2022. The original publication is available at http://link.springer.com/journal/40336 [12 months embargo] | en_US |
dc.subject | Prostate stem cell antigen (PSCA) | en_US |
dc.subject | Metastatic castration-resistant PC (mCRPC) | en_US |
dc.subject | Prostate specific membrane antigen (PSMA) | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | ImmunoPET | en_US |
dc.subject | Precision medicine | en_US |
dc.subject | Positron emission tomography/computed tomography (PET/CT) | en_US |
dc.subject | Castration-resistant prostate cancer | en_US |
dc.subject | Theranostics | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | ImmunoPET for prostate cancer in the PSMA era : do we need other targets? | en_US |
dc.type | Postprint Article | en_US |